Regencell Bioscience
RGC
Market cap $374M

28.75 USD

-3.13

9.82%

Updated Apr 1, 3:59 PM EDT

1 day

-9.82%

5 days

-28.96%

1 month

609.88%

3 months

496.47%

6 months

433.40%

Year to date

496.47%

1 year

637.18%

5 years

173.81%

10 years

25.71%

Healthcare Medicinal Chemicals & Botanical Products

Funds holding %

of 7,398 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

55% more capital invested

Capital invested by funds: $100K [Q3] → $156K (+$55.4K) [Q4]

50% more funds holding

Funds holding: 2 [Q3] → 3 (+1) [Q4]

0.1% more ownership

Funds ownership: 0.14% [Q3] → 0.24% (+0.1%) [Q4]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for RGC.

See Analyst Rankings

Financial journalist opinion

Positive

InvestorPlace

8 months ago

What Is Going on With Regencell Bioscience (RGC) Stock Today?

Little-known drug manufacturer Regencell Bioscience (NASDAQ: RGC ) saw its shares skyrocket on Tuesday on no apparent catalyst. However, it's possible that the exceptionally distinct business profile — specializing in traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders — caught the attention of speculators.

See News Rankings

Charts implemented using Lightweight Charts™